TY - JOUR
T1 - GPR81, a cell-surface receptor for lactate, regulates intestinal homeostasis and protects mice from experimental colitis
AU - Ranganathan, Punithavathi
AU - Shanmugam, Arul Kumaran
AU - Swafford, Daniel
AU - Suryawanshi, Amol
AU - Bhattacharjee, Pushpak
AU - Hussein, Mohamed S.
AU - Koni, Pandelakis
AU - Prasad, Puttur D
AU - Kurago, Zoya Bronislavovna
AU - Thangaraju, Muthusamy
AU - Ganapathy, Vadivel
AU - Manicassamy, Santhakumar
N1 - Funding Information:
This work was supported by National Institutes of Health Grant DK097271 (to S.M.).
Publisher Copyright:
© 2018 by The American Association of Immunologists, Inc. All rights reserved.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - At mucosal sites such as the intestine, the immune system launches robust immunity against invading pathogens while maintaining a state of tolerance to commensal flora and ingested food Ags. The molecular mechanisms underlying this phenomenon remain poorly understood. In this study, we report that signaling by GPR81, a receptor for lactate, in colonic dendritic cells and macrophages plays an important role in suppressing colonic inflammation and restoring colonic homeostasis. Genetic deletion of GPR81 in mice led to increased Th1/Th17 cell differentiation and reduced regulatory T cell differentiation, resulting in enhanced susceptibility to colonic inflammation. This was due to increased production of proinflammatory cytokines (IL-6, IL-1β, and TNF-α) and decreased expression of immune regulatory factors (IL-10, retinoic acid, and IDO) by intestinal APCs lacking GPR81. Consistent with these findings, pharmacological activation of GPR81 decreased inflammatory cytokine expression and ameliorated colonic inflammation. Taken together, these findings identify a new and important role for the GPR81 signaling pathway in regulating immune tolerance and colonic inflammation. Thus, manipulation of the GPR81 pathway could provide novel opportunities for enhancing regulatory responses and treating colonic inflammation.
AB - At mucosal sites such as the intestine, the immune system launches robust immunity against invading pathogens while maintaining a state of tolerance to commensal flora and ingested food Ags. The molecular mechanisms underlying this phenomenon remain poorly understood. In this study, we report that signaling by GPR81, a receptor for lactate, in colonic dendritic cells and macrophages plays an important role in suppressing colonic inflammation and restoring colonic homeostasis. Genetic deletion of GPR81 in mice led to increased Th1/Th17 cell differentiation and reduced regulatory T cell differentiation, resulting in enhanced susceptibility to colonic inflammation. This was due to increased production of proinflammatory cytokines (IL-6, IL-1β, and TNF-α) and decreased expression of immune regulatory factors (IL-10, retinoic acid, and IDO) by intestinal APCs lacking GPR81. Consistent with these findings, pharmacological activation of GPR81 decreased inflammatory cytokine expression and ameliorated colonic inflammation. Taken together, these findings identify a new and important role for the GPR81 signaling pathway in regulating immune tolerance and colonic inflammation. Thus, manipulation of the GPR81 pathway could provide novel opportunities for enhancing regulatory responses and treating colonic inflammation.
UR - http://www.scopus.com/inward/record.url?scp=85044762873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044762873&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1700604
DO - 10.4049/jimmunol.1700604
M3 - Article
C2 - 29386257
AN - SCOPUS:85044762873
SN - 0022-1767
VL - 200
SP - 1781
EP - 1789
JO - Journal of Immunology
JF - Journal of Immunology
IS - 5
ER -